HER2-positive Breast Cancer Registry

Last updated: September 30, 2024
Sponsor: Priyanka Sharma
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT06603597
160944
  • Ages > 18
  • All Genders

Study Summary

The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Stage I-IV HER2-positive breast cancer

Exclusion

Exclusion Criteria:

  • None

Study Design

Total Participants: 1000
Study Start date:
September 27, 2024
Estimated Completion Date:
October 31, 2044

Connect with a study center

  • KCCC Overland Park

    Overland Park, Kansas 66215
    United States

    Site Not Available

  • KUCC - Indian Creek

    Overland Park, Kansas 66211
    United States

    Site Not Available

  • The University of Kansas Cancer Center

    Westwood, Kansas 66205
    United States

    Active - Recruiting

  • KUCC - North

    Kansas City, Missouri 64154
    United States

    Site Not Available

  • KUCC - Lee's Summit

    Lee's Summit, Missouri 64064
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.